4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-23-056349
Chief Financial Officer gave up 2,117 shares (to pay taxes)
- Chief Financial Officer acquired 5,433 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2023-11-18 | Option exercise | +1,752 | 97,836 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-11-18 | Shares withheld for taxes | −683 | $5.98 | $4,084 | 97,153 | D |
| Jeanmonod Patrik Chief Financial Officer | 2023-11-18 | Option exercise | +3,681 | 100,834 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-11-18 | Shares withheld for taxes | −1,434 | $5.98 | $8,575 | 99,400 | D |
| Derivatives | |||||||
| Jeanmonod Patrik Chief Financial Officer | 2023-11-18 | Option exercise · Restricted Stock Units | −1,752 | 15,194 | D | ||
| Jeanmonod Patrik Chief Financial Officer | 2023-11-18 | Option exercise · Restricted Stock Units | −3,681 | 49,090 | D | ||
Loading xslF345X05/doc4.xml…